QT Imaging (NASDAQ:QTI – Get Free Report) is expected to be issuing its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect the company to announce earnings of ($0.22) per share and revenue of $7.60 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Friday, August 14, 2026 at 9:30 AM ET.
QT Imaging (NASDAQ:QTI – Get Free Report) last issued its quarterly earnings results on Wednesday, May 13th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.11). QT Imaging had a negative return on equity of 4,220.38% and a negative net margin of 58.93%.The business had revenue of $6.53 million for the quarter, compared to analyst estimates of $6.45 million. On average, analysts expect QT Imaging to post $-1 EPS for the current fiscal year and $-0 EPS for the next fiscal year.
QT Imaging Stock Performance
Shares of QTI opened at $2.73 on Wednesday. The company has a current ratio of 2.49, a quick ratio of 1.69 and a debt-to-equity ratio of 1.38. The firm has a market cap of $37.59 million, a PE ratio of -2.20 and a beta of -0.01. QT Imaging has a 12 month low of $1.55 and a 12 month high of $8.50. The stock has a fifty day moving average price of $3.68 and a 200-day moving average price of $5.27.
Analyst Ratings Changes
Get Our Latest Stock Analysis on QT Imaging
About QT Imaging
QT Imaging Ltd. (NASDAQ: QTI) is a medical technology company specializing in the development and commercialization of advanced ultrasound imaging solutions. The company focuses on real-time volumetric imaging systems designed to enhance diagnostic capabilities in obstetrics, gynecology and other clinical applications. QT Imaging’s flagship Q.VIEW® system and associated software suite enable practitioners to capture, analyze and visualize high-resolution 3D/4D ultrasound images, offering improved workflow efficiency and enhanced patient care.
QT Imaging’s product portfolio includes proprietary transducers, imaging consoles and software platforms that can be integrated with existing ultrasound scanners from leading original equipment manufacturers.
Featured Stories
- Five stocks we like better than QT Imaging
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for QT Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QT Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
